REG - FIL Limited Medtronic, Inc. Covidien plc - Form 8.3 - COVIDIEN PLC <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>

MedtronicAnnouncement

29/10/2014 13:46

RNS Number : 9215U
FIL Limited
21 October 2014
FORM 8.3
 IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
 FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
COVIDIEN PLC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
20-October-14
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities 
18,375,789 4.06

(2) Derivatives (other than options)
 
 
(3) Options and agreements to purchase/sell
 
 
Total
18,375,789 4.06
 
Please note that the above positions include cancelled purchases for 33 shares from 16 Oct 2014. 
b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(91) Relevant securities 
 
 
(2) Derivatives (other than options)
 
 
(3) Options and agreements to purchase/sell
 
 
Total
 
 
3. DEALINGS(Note 4)
(91) Purchases and sales
Purchase/sale
Number of securities
Price per unit
Buy
132,500
83.3653 USD/ Share
Buy
8,100
83.8883 USD/ Share
Buy
5,900
84.4412 USD/ Share
Buy
2,500
84.6356 USD/ Share
Buy
15,600
83.2600 USD/ Share
Sale
2
85.4400 USD/ Share
Buy
16
85.3300 USD/ Share
Buy
147
83.0200 USD/ Share
Buy
2
82.3900 USD/ Share
Buy
67
85.3400 USD/ Share
Buy
6
82.3700 USD/ Share
Buy
5
83.0100 USD/ Share
Sale
161
83.0200 USD/ Share
Sale
26
82.3900 USD/ Share
Sale
26
85.2900 USD/ Share
(b) Derivatives transactions (other than options transactions)
Product name, 
e.g. CFD
Nature of transaction (Note 6)
Number of securities (Note 7)
Price per unit (Note 5)




(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price 
Type, e.g. American, European etc.
Expiry 
date
Option money
paid/received per unit (Note 5) 







(ii) Exercising
Product name, e.g. call option
Number of securities 
Exercise price per unit (Note 5)


(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)


4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. 
Is a Supplemental Form 8 attached?(Note 9)NO
Date of disclosure
21 October 2014
Contact name
Nevelina Rousseva-Gasnier
Telephone number
+44 (0)1737 837216
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A

This information is provided by RNS
The company news service from the London Stock Exchange
  END
ISELLFSSILLLFIS